US$ 22.05
oral glutathione melasma trial New and topical approaches for the treatment of Lack of efficacy of oral
Description
doi: 10.1172/JCI18182

Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and Exacerbations
V.WhitbyP

Fatostatin (7.5-30 mg/kg), an inhibitor of SREBP activation, reduces intracellular cholesterol accumulation and mitigates ER stress
